Tempus AI, a healthcare-technology company backed by SoftBank, is seeking a valuation of up to $6.1 billion in its upcoming U.S. IPO. The precision medicine company has set terms for the IPO, aiming to raise $400 million by offering 11.1 million shares priced between $35.00 and $37.00 each. The trade date is set for Friday, June 14. Tempus AI, which focuses on creating intelligent diagnostics, has seen significant growth since adding 'AI' to its name five months ago. The company, trading under the ticker $TEM, is led by a co-founder of Groupon. Market Cap: $5.8b-$6.1b.